Navigation Links
Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients
Date:6/2/2009

their caregivers. In September 2008, Medivation announced a global agreement with Pfizer Inc to develop and commercialize Dimebon for the treatment of Alzheimer's and Huntington's diseases. With Pfizer, the Company is conducting a broad Dimebon clinical development program that includes several Phase 3 trials assessing the efficacy and safety of Dimebon taken alone or in combination with other Alzheimer's medication in patients with mild, moderate or severe Alzheimer's disease. Further development of Dimebon in patients with Huntington's disease is also planned. In addition, a Phase 1-2 clinical trial of MDV3100 in patients with castration-resistant (also known as hormone-refractory) prostate cancer is ongoing. For more information, please visit us at http://www.medivation.com.

This press release contains forward-looking statements, including statements regarding the timing and potential results of Phase 3 trials of MDV3100, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause Medivation's actual results to differ significantly from those projected, including, without limitation, risks related to progress, timing and results of Medivation's clinical trials, difficulties or delays in obtaining regulatory approval, enrollment of patients in Medivation's clinical trials, partnering of Medivation's product candidates, manufacturing of Medivation's product candidates, competition with Medivation's product candidates should they receive marketing approval, the adequacy of Medivation's financial resources, unanticipated expenditures or liabilities, intellectual property
'/>"/>

SOURCE Medivation, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimers Disease
2. Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients
3. Medivation Presents Positive New Data on Dimebons Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimers Disease
4. Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimers Disease
5. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
6. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
7. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
8. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting
9. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
10. Medivations Dimebon(TM) Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year
11. Medivations Dimebon(TM) Significantly Improved Daily Function in Alzheimers Disease Patients, Resulting in Reduced Need for Caregiver Assistance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... FREDERICK, Md. , May 23, 2013  BioElectronics ... safe consumer medical devices, comments on the FDA panel ... Public Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting ... Gaithersburg, MD , USA.  The focus of the ... instructed the panel to focus solely on the application ...
(Date:5/23/2013)... , May 23, 2013 Halozyme ... announced the appointment of David A. ... Ramsay was most recently Vice President, Corporate Development ... )     "With his established financial management ... gained by working in our commercial group for ...
(Date:5/23/2013)... -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ), the ... a company overview at the Deutsche Bank 38 th ... at 8:40 a.m. ET in Boston, MA. ... will be available on the "Investors & Media" section of ... be available on the Isis Web site within 48 hours ...
Breaking Medicine Technology:BioElectronics and Pulsed Shortwave Therapy Make Progress 2Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2
... July 18, 2011 Science, public health, and regulatory ... nformation in this document is designed for credentialed journalists. Release ... 18, 2011. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... regulatory or enforcement actions due to legal limitations. ...
... Children,s Hospital is the first hospital in the ... laser technology to destroy lesions in the brain ... (Photo: http://photos.prnewswire.com/prnh/20110718/DC36561-a ) (Photo: ... ) According to hospital experts, this ...
Cached Medicine Technology:FDA News & Notes - Week of July 18, 2011 2FDA News & Notes - Week of July 18, 2011 3FDA News & Notes - Week of July 18, 2011 4Texas Children's Hospital Pioneers Use of MRI-guided Laser Surgery for Revolutionary New Epilepsy Treatment 2Texas Children's Hospital Pioneers Use of MRI-guided Laser Surgery for Revolutionary New Epilepsy Treatment 3Texas Children's Hospital Pioneers Use of MRI-guided Laser Surgery for Revolutionary New Epilepsy Treatment 4Texas Children's Hospital Pioneers Use of MRI-guided Laser Surgery for Revolutionary New Epilepsy Treatment 5
(Date:5/23/2013)... (PRWEB) May 23, 2013 Kantar ... announced the availability of CancerMPact® Biomarker Analysis , ... current and evolving oncology landscape. The analysis ... recently published data covering the following biomarkers: , *BRAF ... cell lung cancer) , *KRAS (colorectal cancer) , *TNBC ...
(Date:5/23/2013)... May 23, 2013 Sharon Kleyne and ... a new product to supplement natural tear film water ... The product, Nature’s Tears® EyeMist®, according to Kleyne, is ... a 100% fresh water mist to the air around ... Kleyne, who describes herself as “educator, inventor, radio commentator ...
(Date:5/23/2013)... 23, 2013 With crowded gyms, bodyweight ... But according to Mike Whitfield, a bodyweight expert in ... like the medicine ball can add a whole new ... BodyweightTorch.com, a website in which anyone can download a ... equipment. Recently, he shared a video with his subscribers ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Studies show that ... times per week are less likely to be overweight, less ... perform better academically, and have better relationships with their parents. ... in danger, according to family dinner expert and advocate ... have declined by 33 percent. When families do eat together, ...
(Date:5/23/2013)... CA (PRWEB) May 23, 2013 ... that their condition specific remedies are now available at ... Laguna Niguel, CA 92677. The line of natural biotherapy ... Foods Market Chain. , Represented by Brandstorm HBC (Los ... Whole Foods Markets throughout California, Nevada and Arizona, as ...
Breaking Medicine News(10 mins):Health News:Kantar Health Launches CancerMPact Biomarker Analysis 2Health News:Water Entrepreneur Announces First Ever Personal Dry Eye Humidifier 2Health News:Unique Ab Exercise, the Medicine Ball Chop, Released from BodyweightTorch.com 2Health News:Family Dinner Expert and Cookbook Author Announces “Family Dinner Challenge” 2Health News:Dr. Garber's Natural Solutions Now Available at Whole Foods Market, Laguna Niguel, CA 2
... ... The award will be used learn how African health care providers are collaborating with ... acute medical care in Africa. , ... Baltimore, Maryland (PRWEB) September 8, 2009 -- The recent tragic death ...
... , ... healing testimonial for ColorAlchemy by licensed Marriage and Family Therapist and Clinical Hypnotherapist David Swindoll ... ... Family Therapist and Clinical Hypnotherapist for over thirty years. He has found the use of ...
... efforts focused on the community pay off, study finds ... and delinquent behavior among teens was significantly reduced in ... study found. , The Communities That Care prevention system, ... seven states, slashed alcohol use by eighth graders by ...
... HEIDELBERG, Germany, September 7 SYGNIS Pharma,AG (Frankfurt: ... present at the 11th Rodman & Renshaw Annual Global,Investment Conference, ... The presentation will be given by Prof. Karoly Nikolich, CEO ... 2:25 p.m. EDT (20:25,CET) in the Garrison Salon. , ...
... LONDON, September 7 Bounty, the UK,s favourite parenting,club, today ... help,expectant and new mums take a real life, close up peek ... To view the Multimedia News Release, please ... Breastfeeding is the healthiest and most natural way ...
... Institutes of Health Research (CIHR) has announced a grant totaling ... on Alzheimer,s disease. MacDonald is the Director of the ... "If you have a stroke and survive, you have a ... These diseases are already taking a huge toll on ...
Cached Medicine News:Health News:Medical Student Wins Travel Scholarship to Kenya to Study Operative Care in Africa 2Health News:Medical Student Wins Travel Scholarship to Kenya to Study Operative Care in Africa 3Health News:Licensed Marriage and Family Therapist and Clinical Hypnotherapist Provides Powerful Video Testimony for ColorAlchemy and Color Therapy 2Health News:Licensed Marriage and Family Therapist and Clinical Hypnotherapist Provides Powerful Video Testimony for ColorAlchemy and Color Therapy 3Health News:Program Curbs Teen Substance Abuse, Delinquency 2Health News:SYGNIS to Present at the 11th Rodman & Renshaw Annual Global Investment Conference 2Health News:Bounty Parenting Club Launches View on Demand 'How to Breastfeed' Video 2Health News:Million dollar boost to Alzheimer's and stroke research at Robarts 2
7 mm strong curved blade. Round handle....
3 mm diameter roller blade in line with handle. Curved shaft. Flat handle. 15 mm from curve to tip....
5 mm diameter blade. Angled 45 degrees. Hexagonal handle....
0.5 mm wide x 1.5 mm long. Angled 20 degrees. Octagonal handle....
Medicine Products: